INVESTMENTS (Narrative) (Details) - 12 months ended Dec. 31, 2023 $ / shares in Units, € in Millions, $ in Millions	EUR (€)	USD ($)	$ / shares	USD ($) $ / shares shares
Schedule of Investments [Line Items]
Number of warrants | shares				11,250
Purchase of common stock	€ 2.0	$ 2.4
Investment description	the Company owns approximately 9.6% of the investee, or approximately 9% on a diluted basis including exercisable warrants of the Company and other investors.	the Company owns approximately 9.6% of the investee, or approximately 9% on a diluted basis including exercisable warrants of the Company and other investors.
Cumulative Impairment		$ 2.9
Net carrying value				$ 0.0
Description of impairment	the investee common shares were valued considering price to book value and price to tangible book value of the investee (3.6 and 4.8, respectively) as well as comparable guideline publicly traded companies at the time of initial investment. These initial investment multiples were compared to the guideline public company multiples observed as at December 31, 2023 (negligible or nil price to book and price to tangible values), with these updated valuation multiples applied to the investee's estimated book value.	the investee common shares were valued considering price to book value and price to tangible book value of the investee (3.6 and 4.8, respectively) as well as comparable guideline publicly traded companies at the time of initial investment. These initial investment multiples were compared to the guideline public company multiples observed as at December 31, 2023 (negligible or nil price to book and price to tangible values), with these updated valuation multiples applied to the investee's estimated book value.
First Tranche [Member]
Schedule of Investments [Line Items]
Share price per share | (per share)			$ 0.3	$ 0.22
Second Tranche [Member]
Schedule of Investments [Line Items]
Share price per share | (per share)			$ 1	$ 0.74